Environmental sustainability: the EIPG perspective
Piero Iamartino Although the impact of medicines on the environment has been highlighted since the 70s of the…
The debate on the “Do No Significant Harm” principle in R&D
by Giulianna Miglierini The “Do No Significant Harm” (DNSH) principle is a widely diffused approach aimed to guarantee…
Some perspectives on green pharmaceuticals
by Giuliana Miglierini The central role the green agenda plays within the EU Commission’s transformative policies impacts also…